** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** While they clung to the ...
- Results from the BL-B01D1-303 (NCT06118333) phase III trial presented in a late-breaking oral presentation at ESMO represents the first data readout for iza-bren from a registration enabling study ...
The Launch Event focused on the BL-B01D1-303 study (hereinafter: 303 Study) led by Chinese scholars. The study evaluated the efficacy and safety of iza-bren for later-line treatment of ...
Multiple clinical studies, including the 303 Study, have shown excellent efficacy data, fully validating the advantages of its mechanism of action. At this ESMO Congress, iza-bren also announced for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback